Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Kidney & Renal Pelvis (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Recentaapc

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


District of Columbia6


Massachusetts7


Arizona6


Washington5


Kansas6


Michigan6


Puerto Rico6


Hawaii7


Rhode Island6


Connecticut7


Florida6


Pennsylvania6


Vermont6


California7


Illinois7


New Jersey7


Delaware6


Kentucky7


North Carolina6


Virginia6


Colorado6


Maine6


New York7


Ohio6


Oregon6


Louisiana7


Alaska6


New Hampshire6


Missouri6


Iowa7


Nebraska6


South Carolina6


Minnesota6


Wyoming6


South Dakota6


New Mexico7


Wisconsin6


Georgia7


North Dakota6


Texas7


Tennessee6


Alabama6


Idaho7


Montana6


Mississippi6


Oklahoma6


West Virginia6


Utah7


Maryland6


Arkansas6


Indiana6 Nevada6

Notes:
Created by statecancerprofiles.cancer.gov on 07/24/2024 1:57 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.